Vedolizumab-induced cholestatic liver injury. Rojas-Feria M, Rodriguez-Fernandez M, Castro-Fernandez M, Suarez-Garcia E, et al. Gastroenterol Hepatol 2022;45:64-65.

Read + Share

Amedeo Smart

Independent Medical Education

Rojas-Feria M, Rodriguez-Fernandez M, Castro-Fernandez M, Suarez-Garcia E, et al. Vedolizumab-induced cholestatic liver injury. Gastroenterol Hepatol 2022;45:64-65.
PMID: 33248173